Determining the ideal retatrutide amount is critically necessary for obtaining optimal benefits. Initially, patients typically commence with a low amount of roughly 2.4 mg, given each week via subcutaneous . This starting amount is then incrementally boosted every four weeks , until a highest amount of 10.8 mg, according to individual reaction and